Pharmaceutical manufacturing equipment including measuring devices
Infrared-based temperature detection in pharmaceutical manufacturing equipment addresses the challenge of flexible and reliable capsule seal inspection, enabling automated detection and sorting of defective seals by monitoring temperature changes during sealing and drying processes.
Patent Information
- Application Number
- JP2024534424
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-08
- Filing Date
- 2022-10-13
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2042-10-13
AI Technical Summary
Existing pharmaceutical manufacturing equipment lacks a flexible and reliable method for detecting the sealing state of capsules, particularly in the presence of similar materials like gelatin, which complicates the identification of defective seals.
Incorporating an infrared camera or a camera with an infrared filter to detect temperature changes during the application and drying of sealing liquid, allowing for image-based temperature detection of the sealing area and adjacent capsule sections, and using an evaluation unit for automated inspection.
Enables simple and reliable detection of sealing states and dryness of capsules, facilitating the identification and automatic sorting of defective seals, while optimizing sealing liquid application based on material properties and position.
Smart Images

Figure 2024545159000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a pharmaceutical production installation equipped with a measuring device for monitoring the sealing of capsules, the capsules having a capsule shell formed by a first shell part and a second shell part, the shell parts being provided with an hermetic sealing liquid in the sealing area. [Background technology]
[0002] A capsule filling and sealing device is known, for example from US 2005 / 0217207 A1. The device comprises a filling unit for filling the open shell parts of the capsules and a sealing unit for sealing the two shell parts of the capsules to be joined to one another. The aforementioned units are passed by the capsule parts to be filled or the capsules to be provided with a seal. The sealing unit comprises a line sensor camera for inspecting the sealing state of the joint section of the sealed capsules, with a view to sorting out capsules with sealing errors.
[0003] The device known from US 2005 / 0217207 A1 makes it possible to generate a two-dimensional image of the capsules using a line sensor camera and to inspect the sealing state of the capsules on the basis of this image. Line sensor cameras are suitable for banding sections that are clearly different in color from adjacent capsule sections. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] US Patent Application Publication No. 2005 / 0217207 Summary of the Invention [Problem to be solved by the invention]
[0005] Given this, the problem underlying the invention is to enable a more flexible detection of the sealing state. [Means for solving the problem]
[0006] This problem is solved in a pharmaceutical manufacturing installation of the type mentioned at the beginning in that the measuring device comprises an infrared camera or a camera with an infrared filter, and the measuring device detects the temperature or temperature changes of the sealing area and / or the capsule section adjacent to the sealing area.
[0007] An infrared camera or a camera equipped with an infrared filter makes it possible to detect infrared radiation and thus to detect by means of an image the temperature of at least one partial region of the capsule.
[0008] According to the invention, it has been found that the application and drying of the sealing liquid is accompanied by temperature changes which are characteristic for the different sealing states of the capsules. The application of the still fluid and warm sealing liquid, for example, is first accompanied by a heat input to the sealing area. Such a heat input can be detected by an infrared camera or a camera equipped with an infrared filter.
[0009] During the subsequent drying of the sealing liquid, the solvent of the sealing liquid evaporates, thereby extracting heat from the sealing liquid, such heat extraction being detectable by an infrared camera or a camera equipped with an infrared filter, for example by detecting cooling of the capsule section and / or by detecting a changed ambient temperature of the capsule.
[0010] The production installation according to the invention allows simple and reliable detection of the sealing state of the capsules and the drying state of the sealing liquid, without the need for color differentiation of the sealing liquid and adjacent capsule sections for this purpose. Furthermore, by image-based temperature detection it is possible to determine the position, orientation and spatial extent of the sealing liquid.
[0011] The sealing liquid in particular consists of the same material as the capsule, for example gelatin. The sealing liquid may also be a sealing liquid (in which case the sealing part comprises or is formed by a sealing part).
[0012] In an advantageous embodiment, the pharmaceutical production facility comprises an evaluation unit, which is configured to automatically evaluate the temperature and / or temperature changes detected by the measuring device. This allows for at least a fully automated inspection of the capsules with respect to a desired sealing state. For example, capsules with defective closures can be identified and ideally automatically sorted out.
[0013] It is furthermore advantageous if the pharmaceutical manufacturing installation comprises a sealing device for sealing the capsules and a control unit, which sets method parameters, in particular with regard to the duration and / or amount and / or position of applying the sealing liquid onto one capsule.
[0014] In an advantageous embodiment, the sealing device is configured to apply a sealing liquid over the sealing area of the capsule shell, for example with the first shell part and the second shell part already joined to one another, thereby producing a hermetic seal in the form of a band seal.
[0015] In an additional or alternative embodiment, the sealing device is configured to apply a sealing liquid to a sealing area on an inner or outer surface of one shell portion that is not yet joined to another shell portion, and the shell portions are joined to each other after application of the sealing liquid.
[0016] The control unit makes it possible to optimize the application of the sealing liquid, taking into account the sealing type and the material properties of the capsule and the sealing liquid.
[0017] The pharmaceutical production facility preferably comprises a sealing device, a control unit and a measuring device, which allows the capsule seals to be produced and inspected whilst using a compact production unit.
[0018] Preferably, the pharmaceutical production facility comprises a filling device, by which a powdered or liquid active substance can be filled into capsule shells and then sealed in a sealing device, whereby a measuring device allows a final inspection of the sealing condition.
[0019] Particularly preferably, the control unit communicates with an evaluation unit. The temperature state of the sealing area of the capsule shell is detected by a measuring device and an infrared image is created. This infrared image is evaluated by the evaluation unit. The evaluation unit preferably performs a comparison of the detected actual values with setpoint values stored in the evaluation unit. Depending on such a comparison, the evaluation unit of the control unit can set changed values for the method parameters.
[0020] In a further preferred embodiment, the measuring device is arranged above the sealing device with respect to the direction of gravity, which allows monitoring of the sealing state already during application of the sealing liquid or directly following in time and space the production of the seal without requiring an additional mounting surface.
[0021] Preferably, the pharmaceutical production facility comprises a drying section, along which the capsules are conveyed during drying of the sealing liquid. For example, a plurality of capsules can be distributed along the drying section, the dryness of the capsules increasing in the capsule conveying direction along the drying section.
[0022] In particular, a plurality of measuring devices are provided, which are arranged spatially offset from one another, and each of these measuring devices has an infrared camera or a camera with an infrared filter. For example, the first measuring device is arranged above the sealing device with respect to the direction of gravity. The second measuring device is arranged, for example, in an area adjacent to the sealing device. If the pharmaceutical manufacturing facility includes a drying section, a first measuring device that is spatially arranged in correspondence with the sealing device and monitors the application of the sealing liquid and a second measuring device that is spatially arranged in correspondence with the drying section and monitors the drying process may be provided. The use of a third measuring device and further measuring devices is also possible.
[0023] The object set out at the outset is also achieved by a method having the features of the independent method claim.The configurations and advantages of the method according to the invention have already been explained above in relation to the production plant according to the invention.
[0024] Preferred configurations of the method according to the invention are the subject of dependent claims 9 and 10.
[0025] Further characteristics and advantages of the invention are the subject of the following description of exemplary embodiments and the drawings. [Brief description of the drawings]
[0026] [Figure 1] FIG. 1 is a side view showing one embodiment of a pharmaceutical manufacturing facility equipped with two measurement devices. [Diagram 2] FIG. 1 is a plan view showing a first embodiment of a capsule. [Diagram 3] FIG. 13 is a plan view showing another embodiment of the capsule. [Figure 4] 2 is a diagram showing the temperature states of a plurality of capsules and their sealing portions detected by a first measuring device of the manufacturing equipment shown in FIG. 1. [Diagram 5] 1. FIG. 5 is a diagram corresponding to FIG. 4, showing the temperature states of a plurality of capsules and their sealing parts detected by a second measuring device of the manufacturing equipment shown in FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0027] 1 shows a schematic representation of one embodiment of a pharmaceutical production plant, generally designated 10. The pharmaceutical production plant 10 has a production direction 12 associated with it, along which capsule parts or capsules are treated and processed. Viewed along the production direction 12, the pharmaceutical production plant 10 includes a conveyor belt 14, a sealing device 16, and a drying section 18.
[0028] The transport belt 14 serves to position and transport the shell portions 44 and 46 along the production direction 12 into the sealing apparatus 16 .
[0029] In the sealing device 16, the shell parts 44 and 46 for producing the capsule 20 are sealed hermetically in the sealing region 24 by the sealing liquid 22 (see Figs. 2 and 3).
[0030] The sealing device 16 communicates with a control unit 26, which sets the method parameters regarding the duration and / or amount and / or position of application of the sealing liquid 22 on one capsule 20. For example, the sealing device 16 may be electrically connected to the control unit 26, or the sealing device 16 and the control unit 26 may communicate with each other wirelessly.
[0031] After application of the sealing liquid 22, the sealed capsules 20 reach a drying section 18 along which the capsules 20 are conveyed continuing in the production direction 12, along which the sealing liquid 22 applied to the respective capsules 20 dries.
[0032] The production plant 10 has, for example, two measuring devices 30, 32. The first measuring device 30 is preferably arranged above the sealing device 16 in relation to the direction of gravity 28. The second measuring device 32 is arranged, for example, above the drying section 18 in relation to the direction of gravity 28, in particular in the region of the end of the drying section 18.
[0033] The measuring devices 30, 32 each include an infrared camera 34. By means of the infrared camera 34, the measuring devices 30, 32 detect the temperature and / or temperature changes of the capsule 20, in particular the temperature of the sealed area 24 of the capsule 20.
[0034] A first measuring device 30 (arranged corresponding to the sealing device 16) detects the temperature state of the respective sealing area 24 of each capsule 20 and / or the temperature state of the capsule sections adjacent to the respective sealing area 24, in particular the mutually opposite ends of the shell parts 44 and 46. Figure 4 shows an exemplary diagram of the temperature state detected by the first measuring device 30. Directly following the application of the sealing liquid 22, the sealing area 24 of the capsules 20 has a significantly higher temperature than the laterally adjacent capsule sections of the shell parts 44 and 46 of these capsules 20, which corresponds to the clear contrast between said areas of the capsules 20 in Figure 4.
[0035] A second measuring device 32 (located at one end of the drying section 18) likewise detects the temperature state of the respective sealing area 24 of the respective capsule 20 and / or the temperature state of the capsule sections adjacent to the respective sealing area 24, in particular the mutually opposite ends of the shell parts 44 and 46. Figure 5 exemplarily shows a diagram of the temperature states detected by the second measuring device 32. After at least sufficiently complete drying (with evaporation of the solvent) of the sealing liquid 22 of the capsule 20, the sealing area 24 has a temperature that is sufficiently assimilated to the temperature of the capsule sections adjacent laterally to the shell parts 44 and 46 of this capsule 20, which corresponds to the only weak contrast between the aforementioned areas of the capsule 20 in Figure 5.
[0036] The first measuring device 30 and the second measuring device 32 each communicate with a correspondingly arranged evaluation unit 38, 40. Alternatively, the pharmaceutical production facility 10 has only one common evaluation unit 38 or 40 that communicates with both the first measuring device 30 and the second measuring device 32.
[0037] At least one evaluation unit 38,40 is configured for automatically evaluating the temperatures and / or temperature changes detected by the measuring devices 30,32.
[0038] The first measuring device 30 detects the temperature and / or temperature changes and, by the spatial correspondence of these temperatures, also the positioning, extension length and / or completeness of the seal of the just-manufactured sealed area 24 of the capsule 20.
[0039] The second measuring device 32 detects the temperature and / or temperature changes and, by the spatial correspondence of these temperatures, also the positioning, extension length and / or completeness of the seal of the at least partially dried sealed area 24 of the capsule 20.
[0040] In an alternative embodiment not shown, no drying section 18 is provided. In this case, the capsules 20 remain in the sealing device 16 for a drying period after application of the sealing liquid 22. A measuring device 30 associated with the sealing device 16 preferably detects in this case both the temperature state of the freshly produced sealing area 24 and also the temperature state of the partially or completely dried sealing area 24.
[0041] The evaluation units 38, 40 communicate with the control unit 26. For example, the first evaluation unit 38 and the second evaluation unit 40 may be electrically connected to the control unit 26 or may communicate with each other contactlessly. If one or both evaluation units 38, 40 determine a deviation of the actual values of the position and / or completeness and / or dryness of the sealing area 24 from predefined target values, the method parameters for the operation of the sealing device 16, for example the duration and / or amount and / or position of application of the sealing liquid 22, are automatically adapted by the control unit 26.
[0042] The manufacturing facility 10 is suitable for use with capsules 20 having a variety of different closure styles, as will be explained below with reference to Figures 2 and 3.
[0043] The capsule 20 comprises a capsule shell 42. The capsule shell 42 is formed from a first shell part 44 and a second shell part 46. Each shell part 44 and 46 has a wall 50 extending rotationally symmetrically about a common extending axis 48, the wall 50 defining a chamber 52 serving to accommodate a pharmaceutical active substance. A free end 54 of each shell part 44, 46 is closed, and a second end 56 has an opening 58, 60, respectively, facing the inner chamber 52. The diameter of the opening 58 of the first shell part 44 is larger than the diameter of the opening 60 of the second shell part 46, in which case the opening 60 of the second shell part 46 can be inserted into the opening 58 of the first shell part 44 to form the capsule shell 42.
[0044] 2 shows one embodiment of a capsule 20 with a covered seal 36. Prior to mating of the first shell part 44 and the second shell part 46, application of sealing liquid 22 is performed in the area defined radially outwardly by the second end 56 of the first shell part 44 and radially inwardly by the second end 56 of the second shell part 46.
[0045] Fig. 3 shows an embodiment of the capsule 20 with an outwardly exposed sealing portion 36. The first shell part 44 and the second shell part 46 are interlocked together, similar to the embodiment shown in Fig. 2. The sealing area 24 is disposed radially outward with respect to the wall 50 and is exposed towards the periphery of the capsule 20. Such a sealing area 24 is also referred to as a banding portion.
Claims
1. A pharmaceutical manufacturing facility (10) comprising a measuring device (30, 32) for monitoring the sealing of a capsule (20), the capsule (20) having a capsule shell (42) formed by a first shell portion (44) and a second shell portion (46), the shell portions (44, 46) being provided with a hermetic sealing liquid (22) in a sealing region (24), The pharmaceutical manufacturing facility (10), wherein the measuring device (30, 32) comprises an infrared camera (34) or a camera equipped with an infrared filter, and the measuring device (30, 32) detects the temperature or temperature changes of the sealing area (24) and / or capsule segments adjacent to the sealing area (24).
2. The pharmaceutical manufacturing facility (10) according to claim 1, characterized in that the pharmaceutical manufacturing facility (10) comprises an evaluation unit (38, 40), which is configured to automatically evaluate the temperature and / or the temperature changes detected by the measuring device (30, 32).
3. The pharmaceutical manufacturing facility (10) according to claim 1 or 2, characterized in that it comprises a sealing device (16) for sealing the capsules (20) and a control unit (26), the control unit (26) being adapted to set method parameters relating to the duration and / or amount and / or position of applying the sealing liquid (22) onto one capsule (20).
4. The pharmaceutical production installation (10) according to claim 3, which is dependent on claim 2, characterized in that the control unit (26) is in communication with the evaluation unit (38, 40).
5. The pharmaceutical manufacturing installation (10) according to claim 3 or 4, characterized in that the measuring device (30) is arranged above the sealing device (16) with respect to the direction of gravity (28).
6. The pharmaceutical manufacturing installation (10) according to any one of claims 1 to 5, characterized in that it comprises a drying section (18) along which the capsules (20) are transported while the sealing liquid (22) is drying.
7. 7. A pharmaceutical manufacturing installation (10) as claimed in any one of claims 1 to 6, characterized in that a plurality of measuring devices (30, 32) are provided, arranged spatially offset from one another, each of the measuring devices (30, 32) having an infrared camera (34) or a camera equipped with an infrared filter.
8. A method for monitoring the sealing of a capsule (20), said capsule (20) having a capsule shell (42), said capsule shell (42) being formed by a first shell part (44) and a second shell part (46), said shell parts (44, 46) being provided with or being provided with an hermetic sealing liquid (22) in a sealing area (24), using in particular a pharmaceutical production installation (10) according to any one of claims 1 to 7, a) detecting a temperature or a temperature change in said sealed area (24) and / or in a capsule section adjacent said sealed area (24); b) evaluating the temperature or the change in temperature; The method includes:
9. 9. The method according to claim 8, characterized in that the detecting a) is performed during application of the sealing liquid (22) in the sealing area (24) and / or after application of the sealing liquid (22) in the sealing area (24).
10. 10. The method according to claim 8 or 9, characterized in that the method parameters with regard to the duration and / or the amount and / or the position of application of the sealing liquid (22) on one capsule (20) are adapted in dependence on the temperature or the temperature change detected according to a).
Citation Information
Patent Citations
Inspection system for coating condition of transparent coating solution
JP2008224464A
Capsule-filling and -sealing apparatus
WO2004004628A1
Capsule-filling and sealing apparatus
US20050217207A1
